查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1962086

全球药物发现资讯学市场规模、份额、趋势和成长分析报告（2026-2034）

Global Drug Discovery Informatics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计药物发现资讯学市场将从 2025 年的 39.8 亿美元成长到 2034 年的 87.1 亿美元，2026 年至 2034 年的复合年增长率为 9.1%。

由于药物研发过程日益复杂，以及对高效数据管理解决方案的需求不断增长，药物发现资讯学市场正经历显着增长。药物发现资讯学涵盖多种工具和技术，旨在促进药物研发全生命週期中生物和化学数据的分析、视觉化和管理。随着製药公司加速研发，对能够增强协作和数据整合的资讯学解决方案的需求预计将会增加，该市场预计将稳步扩张。

此外，资讯科技的进步正在推动药物发现资讯学市场的创新。人工智慧 (AI)、机器学习 (ML) 和巨量资料分析的融合正在改变研究人员分析大量资料集的方式，从而能够有效地识别潜在的候选药物。这些技术促进了预测建模、虚拟筛检和资料探勘，显着降低了药物发现所需的时间和成本。随着药物发现资讯学研究不断深入新的调查方法和应用领域，在药物研发效率和创新能力不断提升的推动下，预计该市场将进一步扩张。

此外，研究机构和製药公司之间合作研究和数据共用的重要性日益凸显，正在塑造药物发现资讯学的发展趋势。随着相关人员认识到合作研究的价值，对支援跨平台数据整合和共用的资讯学解决方案的需求预计将会上升。在开放科学倡议的背景下，这一趋势尤其重要，因为数据透明度和可近性对于推进药物发现至关重要。随着药物发现资讯学市场的不断发展，技术进步、共同研究模式以及对数据驱动决策的重视，将在塑造其未来发展轨迹方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球药物发现资讯学市场：按应用领域划分

  • 市场分析、洞察与预测
  • 药物发现
  • 药物研发

第五章：全球药物发现资讯学市场：依功能划分

  • 市场分析、洞察与预测
  • 定序和标靶数据分析
  • 图书馆和资料库的准备工作
  • 对接，分子建模
  • 其他的

第六章 全球药物发现资讯学市场：依最终使用者划分

  • 市场分析、洞察与预测
  • 生技公司
  • 製药公司
  • 受託研究机构
  • 其他的

第七章 全球药物发现资讯学市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd
    • Charles River Laboratories
    • Collaborative Drug DiscoveryInc
    • Eurofins DiscoverX Products
    • Jubliant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd
    • ChemAxon Ltd
    • Albany Molecular Research Inc
    • Oracle
    • Accenture
    • Agilent TechnologiesInc
    • IlluminaInc
简介目录
Product Code: VMR112115285

The Drug Discovery Informatics Market size is expected to reach USD 8.71 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 9.1% during 2026-2034.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Drug Discovery
  • Drug Development

By Function

  • Sequencing and Target Data Analysis
  • Library and Database Preparation
  • Docking, Molecular Modelling
  • Others

By End User

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

COMPANIES PROFILED

  • Certara, Boehringer Ingelheim International GmbH, Infosys Ltd, Charles River Laboratories, Collaborative Drug Discovery, Inc, Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt Ltd, ChemAxon Ltd, Albany Molecular Research Inc, Oracle, Accenture, Agilent Technologies, Inc, Illumina, Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY FUNCTION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Function
  • 5.2. Sequencing and Target Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Library and Database Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Docking, Molecular Modelling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Application
    • 7.2.2 By Function
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Application
    • 7.3.2 By Function
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Application
    • 7.4.2 By Function
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Application
    • 7.5.2 By Function
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Application
    • 7.6.2 By Function
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY INFORMATICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Certara
    • 9.2.2 Boehringer Ingelheim International GmbH
    • 9.2.3 Infosys Ltd
    • 9.2.4 Charles River Laboratories
    • 9.2.5 Collaborative Drug DiscoveryInc
    • 9.2.6 Eurofins DiscoverX Products
    • 9.2.7 Jubliant Biosys
    • 9.2.8 Selvita
    • 9.2.9 Novo Informatics Pvt. Ltd
    • 9.2.10 ChemAxon Ltd
    • 9.2.11 Albany Molecular Research Inc
    • 9.2.12 Oracle
    • 9.2.13 Accenture
    • 9.2.14 Agilent TechnologiesInc
    • 9.2.15 IlluminaInc